The pathophysiology of the severe complications of COVID-19 is still unclear. We report preliminary data providing evidence of complement activation in patients with COVID-19 with different degrees of respiratory failure.
Complement activation in patients with COVID-19: a novel therapeutic target / M. Cugno, P.L. Meroni, R. Gualtierotti, S. Griffini, E. Grovetti, A. Torri, M. Panigada, S. Aliberti, F. Blasi, F. Tedesco, F. Peyvandi. - In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 0091-6749. - (2020). [Epub ahead of print] [10.1016/j.jaci.2020.05.006]
Complement activation in patients with COVID-19: a novel therapeutic target
M. Cugno
Primo
Conceptualization
;P.L. MeroniSecondo
Conceptualization
;R. GualtierottiConceptualization
;S. GriffiniConceptualization
;S. AlibertiConceptualization
;F. BlasiConceptualization
;F. PeyvandiUltimo
Supervision
2020
Abstract
The pathophysiology of the severe complications of COVID-19 is still unclear. We report preliminary data providing evidence of complement activation in patients with COVID-19 with different degrees of respiratory failure.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0091674920306503-main.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
2.11 MB
Formato
Adobe PDF
|
2.11 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
Caricamento pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
